-
Mashup Score: 2
Learn about the remarkable response rate and complete response rate of Lenvosiltamab in multiple myeloma patients. Explore this potential paradigm shift in treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
Find out how combining traditional chemotherapies with Lurbinectedin can improve outcomes in small cell lung cancer. Discover the therapeutic potential of this innovative treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6MOASC 2024 Oncology Summit Archives - 2 month(s) ago
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set a benchmark in oncology, providing … … At the MOASC Annual Oncology Summit & Research Symposium, Dr. Karen Reckamp, MD, MS, a leading figure in medical … … Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic options. Dr. Justin T. … … The field of oncology is witnessing a paradigm shift in the treatment of lymphomas, fueled by the emergence of … …
Source: oncologytube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6MOASC 2024 Oncology Summit Archives - 2 month(s) ago
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set a benchmark in oncology, providing … … At the MOASC Annual Oncology Summit & Research Symposium, Dr. Karen Reckamp, MD, MS, a leading figure in medical … … Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic options. Dr. Justin T. … … The field of oncology is witnessing a paradigm shift in the treatment of lymphomas, fueled by the emergence of … …
Source: oncologytube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Spotlight on Myeloma 2024: Innovations and Insights from ASH - 2 month(s) ago
Stay up-to-date with the latest advancements in multiple myeloma treatment. Discover the benefits of integrating CD38 monoclonal antibodies and quadruplet regimens.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Take a closer look at MEGA-CRISPR, a new tool in cancer therapy. Learn how this RNA-targeting technology is set to redefine precision medicine and revolutionize genetic research.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14FDA Approves Amivantamab with Chemo for First-Line NSCLC with EGFR Exon 20 Insertion Mutations [EXCLUSIVE VIDEO] - 2 month(s) ago
FDA grants approval for amivantamab-vmjw in lung cancer treatment. Find out how this therapy is changing the landscape of NSCLC treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Rusfertide: A New Horizon in Polycythemia Vera Treatment? - 2 month(s) ago
Learn about the promising clinical trials of rusfertide, a revolutionary drug for polycythemia vera, offering hope for more effective management.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3New FDA Approval: Osimertinib (TAGRISSO®) Combined with Chemotherapy for Treating EGFR-Mutated NSCLC - 3 month(s) ago
Learn about the FDA’s recent approval of the cancer treatment drug osimertinib, marketed as Tagrisso. Experience the latest breakthrough in non-small cell lung cancer treatment with osimertinib in combination with chemotherapy. View this @youtube video for more information.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Niraparib Treatment in Patients With Advanced Ovarian Cancer - 3 month(s) ago
Rafael G. Amado, M.D., President, Head of Global Oncology Research and Development, leading and overseeing the company’s global oncology research and development activities. In a pivotal Phase 3 randomized clinical trial, niraparib maintenance therapy has demonstrated remarkable efficacy for patients recently diagnosed with advanced ovarian cancer following initial platinum-based chemotherapy. This trial, involving 384 participants,
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
Plenary Session interview now available: Dr Sundar Jagannath, MD @TischCancer presents #Linvoseltamab yields strong response in #RRMM First 55 seconds below, watch full interview here [5 questions]: https://t.co/Iv7idArXnh https://t.co/808UbCgYzf